FDA Grants Moderna Full Approval to its COVID-19 Vaccine

US

The Food and Drug Administration has granted Moderna’s Covid-19 vaccine full approval for use in people aged 18 and older on Monday. Moderna’s COVID-19 vaccine was available in the U.S. under Emergency Use Authorization (EUA) from December 18, 2020.

Moderna company announces in a press release, “Today announced the U.S. Food and Drug Administration (FDA) has approved the Biologics License Application (BLA) for SPIKEVAX (COVID-19 Vaccine, mRNA) to prevent COVID-19 in individuals 18 years of age and older.”

Moderna is the second to be fully licensed for use in the United States.

You Might Like

The approval was “based on a comprehensive submission package including efficacy and safety data approximately six months after the second dose.”

TRENDING: SHOCKING TESTIMONY Reveals Democrats Were Stealing Overseas and Military Ballots from Michigan, Georgia and Now Arizona Too (VIDEO)

Read the press release below:

“Our COVID-19 vaccine has been administered to hundreds of millions of people around the world, protecting people from COVID-19 infection, hospitalization and death. The totality of real-world data and the full BLA for Spikevax in the United States reaffirms the importance of vaccination against this virus. This is a momentous milestone in Moderna’s history as it is our first product to achieve licensure in the U.S.,” said Stéphane Bancel, Chief Executive Officer of Moderna. “The full licensure of Spikevax in the U.S. now joins that in Canada, Japan, the European Union, the UK, Israel, and other countries, where the adolescent indication is also approved. We are grateful to the U.S. FDA for their thorough review of our application. We are humbled by the role that Spikevax is playing to help end this pandemic.”

The FDA based its decision on the totality of scientific evidence shared by the Company in its submission package, which included follow-up data from the Phase 3 COVE study showing high efficacy and favorable safety approximately six months after the second dose. Moderna also submitted manufacturing and facilities data required by the FDA for licensure. SPIKEVAX has received approval by regulators in more than 70 countries.

Moderna’s COVID-19 vaccine was available under Emergency Use Authorization (EUA) in the U.S. from December 18, 2020. Under an EUA, the FDA has the authority to allow medical products to be used in an emergency to diagnose, treat, or prevent serious or life-threatening diseases or conditions during a declared public health emergency when there are no adequate, approved, and available alternatives. A booster dose of the Moderna COVID-19 vaccine at the 50 µg dose level is authorized for emergency use in the U.S. under EUA for adults 18 years and older. A third dose of the Moderna COVID-19 vaccine at the 100 µg dose level is authorized for emergency use in immunocompromised individuals 18 years of age or older in the United States who have undergone solid organ transplantation, or who are diagnosed with conditions that are considered to have an equivalent level of immunocompromise.

INDICATION (U.S.)

SPIKEVAX (COVID-19 Vaccine, mRNA) is a vaccine indicated for active immunization to prevent coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in individuals 18 years of age and older.

The FDA published a revised “VACCINE INFORMATION FACT SHEET FOR RECIPIENTS AND CAREGIVERS about SPIKEVAX (COVID-19 VACCINE, mRNA) on Monday.

“This Vaccine Information Fact Sheet contains information to help you understand the risks and benefits of SPIKEVAX (COVID-19 Vaccine, mRNA) and the Moderna COVID-19 Vaccine, which you may receive because there is currently a pandemic of COVID-19.”

According to this fact sheet information, people who are planning to receive this vaccine should tell the vaccination provider about all of their medical conditions, including:

  • have any allergies
  • have had myocarditis (inflammation of the heart muscle) or pericarditis (inflammation of the lining outside the heart)
  • have a fever
  • have a bleeding disorder or are on a blood thinner
  • are immunocompromised or are on a medicine that affects your immune system • are pregnant or plan to become pregnant
  • are breastfeeding
  • have received another COVID-19 vaccine
  • have ever fainted in association with an injection

Articles You May Like

Bill Clinton tests positive for COVID-19, urges people to get vaccinated and boosted
Scarborough Suggests DeSantis Attacking The Media Proves He Is Sexist
Unvaccinated blood sees demand increase all around the world
Megyn Kelly, John Stossel Take on Liberal Media Bias, Envy, and Hatred
​Dwayne ‘the Rock’ Johnson admits he stole Snickers from 7-Eleven daily at age 14, says he went and bought all the Snickers ‘to right this wrong’

Leave a Comment - No Links Allowed:

Your email address will not be published. Required fields are marked *